{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:08:27Z","timestamp":1791752907661,"version":"4.3.4"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T00:00:00Z","timestamp":1236729600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004792","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T23:14:05Z","timestamp":1236726845000},"page":"e4792","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":153,"title":["A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme\u2014A Preclinical and Phase I Investigation"],"prefix":"10.1371","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct00258778","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"David","family":"Aviezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Brill-Almon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoseph","family":"Shaaltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hashmueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bartfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mizrachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithan","family":"Galun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,3,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease.","volume":"324","author":"NW Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0010021","article-title":"Enzyme replacement in Gaucher disease.","volume":"1","author":"E Beutler","year":"2004","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ymgme.2006.01.010","article-title":"Lysosomal storage diseases: natural history and ethical and economic aspects.","volume":"88","author":"E Beutler","year":"2006","journal-title":"Mol Genet Metab"},{"key":"ref4","article-title":"Enzyme replacement therapy.","author":"A Zimran","year":"2006"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies.","volume":"68","author":"CM Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme Replacement for Lysosomal Diseases.","volume":"57","author":"RO Brady","year":"2006","journal-title":"Annual Review of Medicine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial.","volume":"285","author":"R Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.","volume":"113","author":"JM Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).","volume":"144","author":"P Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200519010-00001","article-title":"Laronidase treatment of mucopolysaccharidosis I.","volume":"19","author":"EJ Wraith","year":"2005","journal-title":"BioDrugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.","volume":"167","author":"JE Wraith","year":"2008","journal-title":"Eur J Pediatr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tips.2004.01.004","article-title":"New directions in the treatment of Gaucher disease.","volume":"25","author":"AH Futerman","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"ref13","article-title":"Cutting Dosage of Costly Drug Spurs a Debate.","author":"A Pollack","year":"2008"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.","volume":"Sep;5","author":"Y Shaaltiel","year":"2007","journal-title":"Plant Biotechnol J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.320.5875.473","article-title":"Is the drought over for pharming?","volume":"Apr 25;320(5875)","author":"J Kaiser","year":"2008","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1517\/14656566.9.11.1987","article-title":"Imiglucerase and its use for the treatment of Gaucher's disease.","volume":"9","author":"N Weinreb","year":"2008","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"ref17","first-page":"122","article-title":"The long-term international safety experience of imiglucerase therapy for Gaucher disease.","volume":"Feb 90","author":"K Starzyk","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V90.1.43","article-title":"Enzyme Therapy in Gaucher Disease Type 1: Effect of Neutralizing Antibodies to Acid beta-Glucosidase.","volume":"90","author":"E Ponce","year":"1997","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1079-9796(03)00012-3","article-title":"Enzyme therapy of gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies.","volume":"30","author":"H Zhao","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nbt0390-217","article-title":"Production of correctly processed human serum albumin in transgenic plants.","volume":"8","author":"PC Sijmons","year":"1990","journal-title":"Biotechnology (N Y)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/nbt1027","article-title":"Plant cell cultures for the production of recombinant proteins.","volume":"22","author":"S Hellwig","year":"2004","journal-title":"Nat Biotechnol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.1163420","article-title":"Plant science. Using tobacco to treat cancer.","volume":"321","author":"C Arntzen","year":"2008","journal-title":"Science"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:21:22Z","timestamp":1589642482000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004792"}},"subtitle":[],"editor":[{"given":"Paulo Lee","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,3,11]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004792","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,11]]}}}